Literature DB >> 7327552

Familial lecithin-cholesterol acyltransferase: identification of heterozygotes with half-normal enzyme activity and mass.

J J Albers, C Chen, J L Adolphson.   

Abstract

Lecithin-cholesterol acyltransferase (LCAT) mass and activity was measured in Canadian kindred of Italian and Swedish descent with familial LCAT deficiency. Four subjects had LCAT mass of 5.21 +/- 0.87 micrograms/ml (mean +/- SD) and LCAT activity of 98.8 +/- 12.0 nmol/h/ml, well within their respective normal ranges. Five family members, including the parents, the maternal grandmother, and two of four siblings of the LCAT deficient subjects, had enzyme mass (2.85 +/- 0.32 micrograms/ml) and activity (50.8 +/- 6.3 nmol/h/ml) approximately one-half that of normal levels. These presumed heterozygotes had normal levels of apolipoproteins A-I, A-II, B and D. The two subjects with LCAT deficiency had no detectable LCAT mass (below 0.1 microgram/ml) or LCAT activity (below 0.76 nmol/h/ml), apolipoprotein A-I and D levels approximately 50% of normal, and apolipoproteins B and A-II levels only 30-35% of normal. LCAT deficiency in this family is determined by an autosomal recessive mode. Furthermore, LCAT levels and activity are determined by two autosomal codominant alleles, LCATn, the normal LCAT gene, and LCATd, the LCAT deficiency gene.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7327552     DOI: 10.1007/bf00294929

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

1.  An enzymatic method for the determination of the initial rate of cholesterol esterification in human plasma.

Authors:  W Patsch; S Sailer; H Braunsteiner
Journal:  J Lipid Res       Date:  1976-03       Impact factor: 5.922

2.  A method for the determination of the initial rate of reaction of lecithin: cholesterol acyltransferase in human plasma.

Authors:  Y L Marcel; C Vezina
Journal:  Biochim Biophys Acta       Date:  1973-06-21

3.  Characterization and immunoassay of apolipoprotein D.

Authors:  J J Albers; M C Cheung; S L Ewens; J H Tollefson
Journal:  Atherosclerosis       Date:  1981-06       Impact factor: 5.162

4.  Radioimmunoassay of human plasma Lp(a) lipoprotein.

Authors:  J J Albers; J L Adolphson; W R Hazzard
Journal:  J Lipid Res       Date:  1977-05       Impact factor: 5.922

5.  Familial LCAT deficiency. Report of two patients from a Canadian family of Italian and Swedish descent.

Authors:  J Frohlich; W J Godolphin; C E Reeve; K A Evelyn
Journal:  Scand J Clin Lab Invest Suppl       Date:  1978

6.  Quantitation of apolipoprotein A-I of human plasma high density lipoprotein.

Authors:  J J Albers; P W Wahl; V G Cabana; W R Hazzard; J J Hoover
Journal:  Metabolism       Date:  1976-06       Impact factor: 8.694

7.  Immunoassay of human plasma apolipoprotein B.

Authors:  J J Albers; V G Cabana; W R Hazzard
Journal:  Metabolism       Date:  1975-12       Impact factor: 8.694

8.  Genetic control of lecithin-cholesterol acyltransferase (LCAT): measurement of LCAT mass in a large kindred with LCAT deficiency.

Authors:  J J Albers; G Utermann
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

9.  Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase.

Authors:  P V Subbaiah; J J Albers; C H Chen; J D Bagdade
Journal:  J Biol Chem       Date:  1980-10-10       Impact factor: 5.157

10.  Hereditary lecithin cholesterol acyltransferase deficiency. Report of a new family with two afflicted sisters.

Authors:  D Chevet; M P Ramée; P Le Pogamp; R Thomas; M Garré; L G Alcindor
Journal:  Nephron       Date:  1978       Impact factor: 2.847

View more
  1 in total

1.  Familial lecithin-cholesterol acyltransferase deficiency in a Japanese family: evidence for functionally defective enzyme in homozygotes and obligate heterozygotes.

Authors:  J J Albers; C H Chen; J Adolphson; M Sakuma; T Kodama; Y Akanuma
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.